Literature DB >> 2054382

Differential expression of the mouse alpha 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and aging.

K C Carter1, D J Post, J Papaconstantinou.   

Abstract

In this study we investigated the expression of the Balb/c mouse alpha 1-acid glycoprotein genes. Mice, like humans, have two distinct alpha 1-acid glycoprotein mRNAs. As in humans and rats, mouse alpha 1-acid glycoprotein is a strong acute-phase reactant and its expression can be induced by acute-phase stimulatory agents such as bacterial lipopolysaccharides. Southern analysis and partial sequencing of different alpha 1-acid glycoprotein genomic clones indicated the existence of three distinct alpha 1-acid glycoprotein genes in the Balb/c genome. Using oligonucleotide hybridization, we showed that two of the three genes were expressed while the third gene was either not expressed or expressed at extremely low levels. The mRNA levels for the two expressed genes, alpha 1-acid glycoprotein-1 and alpha 1-acid glycoprotein-2, were both induced during the acute-phase response. However, alpha 1-acid glycoprotein-2 mRNA was present in at least 10-fold higher levels in both induced and uninduced mice. There were also differences in the developmental patterns of the two mRNAs in that the constitutive alpha 1-acid glycoprotein-1 mRNA levels increased 20-fold between 2 and 7 months, while alpha 1-acid glycoprotein-2 mRNA pools remained constant. During the acute-phase response in aged animals, there was an increase in the time required for both mRNAs to respond, and the maximum induced level of both mRNAs decreased. These studies set the stage for future experiments to determine the mechanisms by which the different alpha 1-acid glycoprotein genes are regulated during the acute-phase response and how aging affects these regulatory processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054382     DOI: 10.1016/0167-4781(91)90008-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.

Authors:  Bing Zhou; Yunchen Luo; Nana Ji; Cheng Hu; Yan Lu
Journal:  Nat Metab       Date:  2022-09-01

2.  New directions for studying the role of free radicals in aging.

Authors:  M A Pahlavani; H Van Remmen
Journal:  Age (Omaha)       Date:  1997-07

3.  Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers.

Authors:  C C Hsieh; W Xiong; Q Xie; J P Rabek; S G Scott; M R An; P D Reisner; D T Kuninger; J Papaconstantinou
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

4.  Orosomucoid in liver diseases.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

Review 5.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.